Elevated serum TNF-α level as a link between endothelial dysfunction and insulin resistance in normotensive obese patients

Diabetic Medicine

Volumn 16, Issue 3, 1999, Pages 207-211

  Winkler, Gabor ^a   Lakatos, P ^b   Salamon, F ^a   Nagy, Z ^b   Speer, G ^b   Kovacs M ^b   Harmos, G ^a   Dworak, O ^d   Cseh, K ^c  

^a ST JOHN'S HOSPITAL   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c Karolyi Hospital   (Hungary)

^d St John's Hospital ^*

Author keywords

Android type obesity; C peptide; Endothelial dysfunction; Endothelin 1; Serum TNF levels

Indexed keywords

C PEPTIDE; ENDOTHELIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GLUCOSE TOLERANCE; HUMAN; INSULIN RESISTANCE; MALE; OBESITY; VASCULAR ENDOTHELIUM;

ADULT; BODY MASS INDEX; C-PEPTIDE; CASE-CONTROL STUDIES; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INSULIN RESISTANCE; LINEAR MODELS; OBESITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032749917     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.1999.00052.x     Document Type: Article

References (20)

1. 1 Hotamisligil GS, Spiegelman BM. Tumor necrosis factor-α: a key component of the obesity-diabetes link. Diabetes 1994; 43: 1271-1278.
2. 2 Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
3. 3 Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BIJR, Hotamislil GS et al. Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 1994; 134: 264-270.
4. 4 Hotamisligil GS, Peraldi P, Budavary A, Ellis R, Wite MF, Spiegelman BM. IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α-and obesity-induced insulin resistance. Science 1996; 271: 665-668.
5. 5 Stephens JN, Lee J, Pilch PF. Tumor necrosis-alfa induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT-4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem 1997; 272: 971-976.
6. 6 Liu LS, Spelleken N, Röhrig K, Hauner H, Eckel J. Tumor necrosis factor-α acutely inhibits insulin signaling in human adipocytes. Diabetes 1998; 47: 515-522.
7. 7 Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 1997; 389: 610-614.
8. 8 Yudkin DS. The Deidesheimer Meeting: significance of classical and new risk factors in non-insulin-dependent diabetes mellitus. J Diab Compl 1997; 11: 100-103.
9. 9 Kahaleh MB, Fan PS. Effect of cytokines on the production of endothelin by endothelial cells. Clin Exp Rheumatol 1997; 15: 163-167.
10. 10 Hu EM, Levin ER, Pedram A. Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes 1993; 42: 351-358.
11. 11 Cseh K, Beutler B. Alternative cleavage of the cachectin/tumor necrosis factor propeptide results in a larger inactive form of secreted protein. J Biol Chem 1989; 264: 16256-16260.
12. 12 Argilés JM, López-Soriano J, Busquets S, López-Soriano FJ. Journey from cachexia to obesity by TNF. FASEB J 1997; 11: 743-751.
13. 13 Pfeiffer A, Janott J, Möhlig M, Ristow M, Rochlitz H, Busch K et al. Circulating tumor necrosis factor-α is elevated in male but not in female patients with Type II diabetes mellitus. Horm Metab Res 1997; 29: 111-114.
14. 14 Kellerer M, Rett K, Renn W, Groop L, Häring HU. Circulating TNF-alpha and leptin levels in offsprings of NIDDM patients do not correlate to individual insulin sensitivity. Horm Metab Res 1996; 28: 737-743.
15. 15 Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R. Effects of an enginered human anti-TNF-alpha antibody (CDP 571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 1996; 45: 881-885.
16. 16 Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415.
17. 17 Ferri C, Bellini C, Desideri G, Baldoncini R, Properzi G, Santucci A et al. Circulating endothelin-1 levels in obese patients with the metabolic syndrome. Exp Clin Endocrinol Diabetes 1997; 105 (Suppl 2): 38-40.
18. 18 Letizia C, Iannacone A, Cerci S, Santi G, Cilli M, Coassin S et al. Circulating endothelin-1 in non-insulin-dependent diabetic patients with retinopathy. Horm Metab Res 1997; 29: 247-251.
19. 19 Dosquet C, Weil D, Wantier JL. Molecular mechanism of blood monocyte adhesion to vascular endothelial cells. Nouv Rev Fr Hematol 1992; 34: 55-59.
20. 20 Nava P, Collados MT, Masso F, Guarner V. Endothelin mediation of insulin and glucose-induced changes in vascular contractility. Hypertension 1997; 30: 825-829.